Compare NEULAND LABS with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs STERLING BIOTECH - Comparison Results

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS STERLING BIOTECH NEULAND LABS/
STERLING BIOTECH
 
P/E (TTM) x 45.4 -0.4 - View Chart
P/BV x 3.4 0.0 24,105.8% View Chart
Dividend Yield % 0.1 0.0 -  

Financials

 NEULAND LABS   STERLING BIOTECH
EQUITY SHARE DATA
    NEULAND LABS
Mar-20
STERLING BIOTECH
Dec-13
NEULAND LABS/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs75411 7,177.1%   
Low Rs2473 7,273.5%   
Sales per share (Unadj.) Rs594.526.8 2,217.6%  
Earnings per share (Unadj.) Rs12.6-15.0 -84.5%  
Cash flow per share (Unadj.) Rs37.0-5.5 -677.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs553.454.9 1,008.3%  
Shares outstanding (eoy) m12.83267.87 4.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.80.3 324.7%   
Avg P/E ratio x39.6-0.5 -8,525.4%  
P/CF ratio (eoy) x13.5-1.3 -1,062.7%  
Price / Book Value ratio x0.90.1 714.2%  
Dividend payout %15.80-   
Avg Mkt Cap Rs m6,4211,862 344.9%   
No. of employees `0001.31.4 94.7%   
Total wages/salary Rs m1,236547 226.0%   
Avg. sales/employee Rs Th5,949.45,303.3 112.2%   
Avg. wages/employee Rs Th963.8403.8 238.7%   
Avg. net profit/employee Rs Th126.4-2,959.0 -4.3%   
INCOME DATA
Net Sales Rs m7,6277,181 106.2%  
Other income Rs m3943 91.2%   
Total revenues Rs m7,6667,223 106.1%   
Gross profit Rs m1,019947 107.6%  
Depreciation Rs m3132,543 12.3%   
Interest Rs m2164,377 4.9%   
Profit before tax Rs m529-5,931 -8.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m367-1,924 -19.1%   
Profit after tax Rs m162-4,007 -4.0%  
Gross profit margin %13.413.2 101.3%  
Effective tax rate %69.432.4 213.8%   
Net profit margin %2.1-55.8 -3.8%  
BALANCE SHEET DATA
Current assets Rs m5,15214,335 35.9%   
Current liabilities Rs m3,57649,809 7.2%   
Net working cap to sales %20.7-494.0 -4.2%  
Current ratio x1.40.3 500.5%  
Inventory Days Days105403 26.0%  
Debtors Days Days91171 53.3%  
Net fixed assets Rs m3,96955,432 7.2%   
Share capital Rs m129268 48.2%   
"Free" reserves Rs m6,97113,935 50.0%   
Net worth Rs m7,10014,701 48.3%   
Long term debt Rs m7749,478 8.2%   
Total assets Rs m12,31073,988 16.6%  
Interest coverage x3.5-0.4 -972.8%   
Debt to equity ratio x0.10.6 16.9%  
Sales to assets ratio x0.60.1 638.4%   
Return on assets %3.10.5 612.7%  
Return on equity %2.3-27.3 -8.4%  
Return on capital %9.5-6.4 -147.2%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m5,1871,860 278.9%   
Fx outflow Rs m1,59325 6,399.4%   
Net fx Rs m3,5941,835 195.9%   
CASH FLOW
From Operations Rs m5731,719 33.4%  
From Investments Rs m-487-3,148 15.5%  
From Financial Activity Rs m-551,426 -3.8%  
Net Cashflow Rs m33-3 -958.8%  

Share Holding

Indian Promoters % 36.3 33.9 107.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 63.7 0.0 -  
FIIs % 0.0 9.9 -  
ADR/GDR % 0.0 16.9 -  
Free float % 63.7 39.3 162.2%  
Shareholders   12,705 21,482 59.1%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   WYETH  PIRAMAL ENTERPRISES  NATCO PHARMA  SUN PHARMA  PFIZER  

Compare NEULAND LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Mutual Fund Buying Activity in February, Easy Trip Planners IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended their day on a flat note yesterday. At the closing bell yesterday, the BSE Sensex stood higher by 35 points (up 0.1%).

Related Views on News

NEULAND LABS Announces Quarterly Results (3QFY21); Net Profit Up 141.5% (Quarterly Result Update)

Feb 3, 2021 | Updated on Feb 3, 2021

For the quarter ended December 2020, NEULAND LABS has posted a net profit of Rs 267 m (up 141.5% YoY). Sales on the other hand came in at Rs 2 bn (up 20.5% YoY). Read on for a complete analysis of NEULAND LABS's quarterly results.

NEULAND LABS 2019-20 Annual Report Analysis (Annual Result Update)

Sep 2, 2020 | Updated on Sep 2, 2020

Here's an analysis of the annual report of NEULAND LABS for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of NEULAND LABS. Also includes updates on the valuation of NEULAND LABS.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

Charge Your Portfolio with this Smallcap Proxy Play on India's EV Revolution(Profit Hunter)

Mar 5, 2021

This could be the biggest wealth creator of the decade.

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NEULAND LABS SHARE PRICE


Mar 8, 2021 (Close)

TRACK NEULAND LABS

  • Track your investment in NEULAND LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NEULAND LABS 5-YR ANALYSIS

COMPARE NEULAND LABS WITH

MARKET STATS